Volume 14, Issue 2 pp. 150-152

Thrombotic thrombocytopenic purpura in advanced prostate cancer: Case report and published work review

Valeria Caramello

Corresponding Author

Valeria Caramello

Internal Medicine and

Valeria Caramello, md, Internal Medicine Unit, Department of Clinical and Biological Sciences, University of Turin, San Luigi Hospital, Regione Gonzole 10, 10043 Orbassano (Turin), Italy. Email: [email protected]Search for more papers by this author
Andrea Dovio

Andrea Dovio

Internal Medicine and

Search for more papers by this author
Pasquale Caraci

Pasquale Caraci

Internal Medicine and

Search for more papers by this author
Alfredo Berruti

Alfredo Berruti

Oncology Units, Department of Clinical and Biological Sciences, University of Turin, San Luigi Hospital, Orbassano, Turin, Italy

Search for more papers by this author
Alberto Angeli

Alberto Angeli

Internal Medicine and

Search for more papers by this author
First published: 19 January 2007
Citations: 11

All Authors contributed to the management of the patient during hospitalization. V. Caramello and A. Dovio also reviewed the published work on the subject and wrote the manuscript.

Abstract

Abstract:  Thrombotic thrombocytopenic purpura (TTP) is a generalized disorder of the microcirculation characterized by microangiopathic hemolytic anemia (MHA), thrombocytopenic purpura and systemic microvascular thrombi. TTP has been previously described in two patients with prostate cancer (PC). We report a third case of TTP in a 61-year-old man with hormone-refractory bone metastatic PC. The syndrome presented with confusion, anuric acute renal failure, thrombocytopenia and MHA. A satisfactory recovery was achieved after plasma exchange (PE). TTP should be included in the coagulation disorders occurring in PC patients. Early treatment with plasma exchange is recommended in these particular cases.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.